Clinical Trial Update: Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy

View source ↗

Summary

A retrospective study in metastatic renal cell carcinoma evaluating the efficacy and safety of targeted therapies after Pazopanib as first-line therapy. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Pazopanib (Votrient) (Pazopanib)

Snippet

Sponsor: Spanish Oncology Genito-Urinary Group | Conditions: Metastatic Renal Cell Carcinoma | Status: COMPLETED